Model
Edge
Transcode Therapeutics Inc.
RNAZ
Filing Type
8-K
Filing Date
10/7/2025
Updated
10/8/25, 7:57 AM
Filing
8-K
Earnings Release
Exhibits
8-K
Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-2.1
EXHIBIT 2.1
EX-3.1
EXHIBIT 3.1
EX-4.1
EXHIBIT 4.1
EX-10.1
EXHIBIT 10.1
EX-10.2
EXHIBIT 10.2
EX-99.1
Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-99.2
Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Changes in Board, Management or Compensation, Amendments to Articles of Incorporation or Bylaws, Reg. FD
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic